2019 annual financial data
Tempest Therapeutics 2019 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -45,399,000 USD and net income was -44,568,000 USD.
Operating cash flow was -41,222,000 USD.
Get free Tempest Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -45,399,000 USD
- Net income
- -44,568,000 USD
- Operating cash flow
- -41,222,000 USD